References
- NCCN clinical practice guidelines in oncology: antiemesis―version 2.2020. Available from: https://www.nccn.org/professionals/physician_gls/pdf/antiemesis.pdf. Accessed 98, 2020.
- Heron Therapeutics. CinvantiTM (Aprepitant) Injectable Emulsion, for Intravenous Use [Prescribing Information]. San Diego, CA: Heron Therapeutics; 2019.
- HerrstedtJ, RoilaF, WarrD, et al. 2016 Updated MASCC/ESMO consensus recommendations: prevention of nausea and vomiting following high emetic risk chemotherapy. Supportive Care Cancer. 2017;25(1):277–288. doi:10.1007/s00520-016-3313-0
- HeskethPJ, KrisMG, BaschE, et al. Antiemetics: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2017;35(28):3240–3261. doi:10.1200/JCO.2017.74.478928759346
- RoilaF, WarrD, HeskethPJ, et al. 2016 updated MASCC/ESMO consensus recommendations: prevention of nausea and vomiting following moderately emetogenic chemotherapy. Supportive Care Cancer. 2017;25(1):289–294. doi:10.1007/s00520-016-3365-1
- ASHP and the University of Utah Drug Information Service. Small-volume parenteral solutions shortages suggestions for management and conservation. US Food and Drug Administration Web site: 2017. Available from: https://www.fda.gov/downloads/Drugs/DrugSafety/DrugShortages/UCM582461.pdf. Accessed 98, 2020.
- US Food and Drug Administration. FDA Commissioner Scott Gottlieb, M.D, updates on some ongoing shortages related to IV fluids (2018 Jan 16). Available from: https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm592617.htm. Accessed 98, 2020.
- International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. ICH harmonised tripartite guideline. Validation of analytical procedures: text and methodology Q2(R1). Available from: http://academy.gmp-compliance.org/guidemgr/files/Q2(R1).PDF. Accessed 98, 2020.
- Eisai Inc. Aloxi (Palonosetron HCl) Injection for Intravenous Use [Prescribing Information]. Woodcliff Lake, NJ, USA: Eisai Inc; 2020.
- BentleyJ, HeardK, CollinsGCC. Mixing medicines: how to ensure patient safety. Pharmaceut J. 2015;25(294). doi:10.1211/PJ.2015.20068289
- US Food and Drug Administration. FDA Safety Assessment of Di(2-ethylhexyl)phthalate (DEHP) Released from PVC Medical Devices. Available from: https://www.fda.gov/media/114001/download. Accessed 98, 2020.